Advancing the Treatment of Inflammatory Disease
We’re developing innovative therapies that precisely modulate the immune system, reducing harmful inflammation while preserving the body’s natural defenses. Our goal is to bring forward safer, more durable treatments for patients living with immune-driven disease.
Our approach combines advanced antibody engineering, immune pathway modulation, and next-generation biologics to directly target the mechanisms that fuel inflammatory disorders.
- Restore balance across dysregulated cytokine networks
- Reduce tissue damage driven by chronic immune activation
- Improve long-term outcomes across autoimmune and inflammatory diseases
- Unlock new therapeutic options for patients underserved by existing treatments
Our Pipeline
We’re developing first-in-class small molecules and peptide therapeutics to unlock a healthier metabolism safely and effectively.
Join the Future of Inflammatory Disease Treatment
Vial’s clinical research teams are working with investigators across multiple specialties to evaluate the next wave of immunology therapeutics. Individuals with immune-mediated inflammatory conditions may be eligible for early studies.
Contact
Get in touch!
Compose the future with us
"*" indicates required fields
